What does Aardvark Therapeutics, Inc. do?
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
What is Aardvark Therapeutics, Inc.'s P/E and P/B ratio?
Aardvark Therapeutics, Inc. has a P/E ratio of -1.2 and a P/B ratio of 1.16.
What is Aardvark Therapeutics, Inc.'s debt-to-equity ratio?
Aardvark Therapeutics, Inc. has a debt-to-equity ratio of 0.01.
How much does Aardvark Therapeutics, Inc. owe compared with what it owns?
Aardvark Therapeutics, Inc. owes $0.08 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Aardvark Therapeutics, Inc.'s Positivity rank?
Aardvark Therapeutics, Inc. is ranked #1,383 of 6,774 companies globally and #301 of 4,000 in United States on PositoAI, with a Positivity Score of 22,853.
Does Aardvark Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Aardvark Therapeutics, Inc..
Where can I read the latest news about Aardvark Therapeutics, Inc.?
Recent headlines about Aardvark Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Aardvark Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Aardvark Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.